Stock Tip Tuesday

$VERU ( ▼ 0.06% ) Hear me out… Ozempic, but you don’t lose muscle.

Stock
Featured Stock Today NASDAQ $VERU ( ▼ 0.06% ) 

Veru Inc. (NASDAQ: $VERU ( ▼ 0.06% ) ) is a biotech stock that is quietly working on something that could address a major weakness in the current fat people industry….

Weight loss without the muscle loss.

(Disclaimer: VHLA does not support people cutting corners to lose weight, but we do support potentially explosive gains from biotech stocks)

Well, $VERU ( ▼ 0.06% ) had a successful Phase 2b trial, a pivotal Phase 3 in planning, and growing attention from analysts and major investors, Veru Inc. (NASDAQ: $VERU ( ▼ 0.06% ) ) is worth watching.

I’ll save you the headache and give you the top 6 reasons you should be watching $VERU ( ▼ 0.06% ) 

1. Positioned in a Growing $470B+ Industry: The GLP-1 (the Ozempic drug hormone) is projected to expand by over 900%, with rising demand for muscle-preserving weight-loss solutions—an area where Veru Inc. (NASDAQ: VERU) is driving innovation.

2. Recent Clinical Milestones: Veru Inc. (NASDAQ: VERU)’s Phase 2b QUALITY clinical trial delivered positive results, showing that Enobosarm + GLP-1 therapy could significantly reduce muscle loss while increasing fat reduction—a major breakthrough in obesity treatment. In short, it’s like Ozempic, but you stay jacked.

3. Phase 3 Trial on the Horizon: The company has a clear path forward, with a pivotal FDA-regulated Phase 3 trial in planning that could not only further validate Enobosarm’s role in this space but put it as a leader.

4. Bullish Sentiment: Firms like Oppenheimer, B. Riley Financial, and H.C. Wainwright maintains bullish outlooks, with targets reflecting significant upside potential as the company advances its clinical program.

5. Billionaire Takes Stake: Dr. Phillip Frost, a seasoned healthcare investor with a history of successful exits, has taken a significant stake in Veru Inc. $VERU ( ▼ 0.06% ) , securing over 5,000,000 shares - nothing like a billionaire-backed small-cap.

6. Cashed up For Growth: With over $26 million in cash & equivalents in reserve, $VERU ( ▼ 0.06% ) is cashed up, ready to keep pushing forward with presumably little cash issues or dilution events (idk they could raise money). But cash is scarce for small-caps, and a lack of it sends these things to the gutter, but $VERU has some nice runway with $26M. Bullish.

Stock
Analyst Coverage

Analysts and the media fckn love this thing. According to independent valuations the gents over at Simply Wall Street, $VERU ( ▼ 0.06% ) is trading 83% below its fair market value, with an average 1 year price target of $3.25 which is a nice +495% gain from the price at the time of writing this piece.

Simply Wall Street isn’t the only fucking nerds who like this thing.

Barron’s even has this thing rated “Buy” with the lowest price target almost double of today’s stock price.

Stock
Conclusion

Look, we aren’t financial advisors, this isn’t advice, although we made $VERU ( ▼ 0.06% ) sound like a sure opportunity, this shit is risky, this is a fucking casino. So please take it all with a grain of salt and do your own dd. We have no idea of the future price action of Veru Inc, and nobody does, not even the virgin analysts. We currently own no stock in Veru Inc ourselves, but we may buy or sell at any given moment.

Legal
Disclaimer

_{VHLA Media has been engaged by a third party, Goldwyn Media, to provide marketing and advertising services on behalf of Veru Inc. We have received total compensation of USD $5,000 for marketing services, which include, but are not limited to, social media posts, this newsletter, content creation, and other promotional efforts.}

_{VHLA Media does not currently own any shares of Veru Inc. and may or may not buy or sell shares in the future without notice. Our content reflects our own opinions and perspectives and is intended strictly for informational and marketing purposes. Nothing in this communication should be construed as personalized financial advice, a solicitation, or a recommendation to buy or sell any security.}

_{VHLA Media is not a registered investment advisor, broker-dealer, or financial professional in any jurisdiction. We are not licensed or qualified to provide financial advice, and none of the content we create should be interpreted as such. Investing in the stock market involves risk, and readers/viewers should be aware that they could lose part or all of their investment. Always consult with a licensed investment advisor, broker, or financial planner before making any investment decisions.}

_{This communication may contain forward-looking statements that involve known and unknown risks and uncertainties, which may cause actual results to differ materially from those expressed or implied. Veru Inc. is a publicly traded company, and all investors should review its official filings with the U.S. Securities and Exchange Commission (SEC) and any other applicable securities regulatory authorities before making investment decisions.}

_{Do not make any investment decisions based solely on our content. You are solely responsible for your own due diligence.}

_{For further information, please visit Veru Inc.’s official website or consult its publicly available disclosures.}